Brivaracetam

Brivaracetam
Product Description

Indicated for the treatment of partial-onset seizures in patients 4 years of age and older.

OMGENE LIFE SCIENCES PRIVATE LIMITED

  • IN
  • 2020
    On CPHI since
  • 50 - 99
    Employees
Company types
Pharmaceutical company
Specifications
  • CAS Registry Number
    357336-20

OMGENE LIFE SCIENCES PRIVATE LIMITED

  • IN
  • 2020
    On CPHI since
  • 50 - 99
    Employees
Company types
Pharmaceutical company

More Products from OMGENE LIFE SCIENCES PRIVATE LIMITED (44)

  • Tirzepatide

    Product Tirzepatide

    Glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

  • Cetrorelix  Acetate

    Product Cetrorelix Acetate

    Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.
  • Degarelix Acetate

    Product Degarelix Acetate

    Indicated for treatment of patients with advanced prostate cancer.
  • Apremilast

    Product Apremilast

    Indicated in Psoriatic Arthritis, Psoriasis and Oral Ulcers Associated with Behçet’s Disease
  • Bedaquiline Fumarate

    Product Bedaquiline Fumarate

    Diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB).
  • Binimetinib

    Product Binimetinib

    Indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation
  • Carbetocin

    Product Carbetocin

    Used to prevent excessive bleeding after childbirth, particularly following Cesarean section.
  • Crisaborole

    Product Crisaborole

    Indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
  • Deutetrabenazine

    Product Deutetrabenazine

    Indicated for the treatment of chorea associated with Huntington’s disease, tardive dyskinesia in adults.
  • Erdafitinib

    Product Erdafitinib

    Indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuva...
  • Etelcalcetide

    Product Etelcalcetide

    Iindicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
  • Everolimus

    Product Everolimus

    Indicated for Prophylaxis of Organ Rejection in Kidney Transplantation and Prophylaxis of Organ Rejection in Liver Transplantation

OMGENE LIFE SCIENCES PRIVATE LIMITED resources (1)